| 0 (0%) | 02-21 18:36 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 588.52 | 1-year : | 687.39 |
| Resists | First : | 503.87 | Second : | 588.52 |
| Pivot price | 470.7 |
|||
| Supports | First : | 457.6 | Second : | 429 |
| MAs | MA(5) : | 477.05 |
MA(20) : | 471.68 |
| MA(100) : | 442.08 |
MA(250) : | 446.46 |
|
| MACD | MACD : | 3.8 |
Signal : | 4 |
| %K %D | K(14,3) : | 35.8 |
D(3) : | 41 |
| RSI | RSI(14): 54.6 |
|||
| 52-week | High : | 519.67 | Low : | 362.5 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ VRTX ] has closed below upper band by 30.1%. Bollinger Bands are 12.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 479.35 - 482.24 | 482.24 - 485.01 |
| Low: | 458.22 - 461.6 | 461.6 - 464.83 |
| Close: | 471.65 - 476.7 | 476.7 - 481.53 |
Sat, 21 Feb 2026
Tredje AP fonden Sells 65,290 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Sat, 21 Feb 2026
Mitsubishi UFJ Asset Management UK Ltd. Takes Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Sat, 21 Feb 2026
Jupiter Asset Management Ltd. Invests $25.70 Million in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Thu, 19 Feb 2026
Is Vertex Pharmaceuticals (VRTX) Now Offering A Compelling Entry Point After Flat One Year Returns - Yahoo Finance
Thu, 19 Feb 2026
Mcrae Capital Management Inc. Boosts Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Wed, 18 Feb 2026
Insider Sale: EVP and Chief Legal Officer of $VRTX Sells 988 Shares - Quiver Quantitative
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 254 (M) |
| Shares Float | 253 (M) |
| Held by Insiders | 0.1 (%) |
| Held by Institutions | 97.5 (%) |
| Shares Short | 4,420 (K) |
| Shares Short P.Month | 4,290 (K) |
| EPS | 14.05 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 68.19 |
| Profit Margin | 31.3 % |
| Operating Margin | 40.2 % |
| Return on Assets (ttm) | 12 % |
| Return on Equity (ttm) | 22.3 % |
| Qtrly Rev. Growth | 11 % |
| Gross Profit (p.s.) | 24.35 |
| Sales Per Share | 46.19 |
| EBITDA (p.s.) | 18.56 |
| Qtrly Earnings Growth | 4.6 % |
| Operating Cash Flow | 3,720 (M) |
| Levered Free Cash Flow | 2,910 (M) |
| PE Ratio | 33.94 |
| PEG Ratio | 0 |
| Price to Book value | 6.99 |
| Price to Sales | 10.32 |
| Price to Cash Flow | 32.52 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|